IPOs: Too many, too fast, to little buyers? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : IPOs: Too many, too fast, to little buyers?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: RockyBalboa who wrote (57)	1/22/2001 12:11:11 AM
From: Mad2	Read Replies (1) of 84

That 1 bil is from a secondary last spring. CRA is a imagine stock. As in imagine if they make good on their effort to couple their data in genomics with computational power to unlock relationships leading that point to drug opportunities. company claims that results should be forthcomming in 12-24 months. Its interesting that CRA was a creation of the old Perkin Elmer (eg PE) and their claim to fame lay in advancing the ability to perform the DNA sequencing faster, with improvements in the machines. Now they are hooking with Sandia and Compaq with the purpose of speeding the analysis. C, hard to say were it'll all end up, however if there is one area that could lead to immense value creation its genomic information. For now CRA seems to be the bluest chip of the bunch (INCY, Human Genome and Rossetta) We shall see mad2

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next